William Jacob Savage Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

William Jacob Savage is Chief Medical Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 43,405 shares of GMTX, which is worth approximately $1.06 Million. The most recent transaction as insider was on Apr 10, 2024, when has been sold 21,870 shares (Common Stock) at a price of $2.65 per share, resulting in proceeds of $57,955. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.4K
101.56% 3M change
172.29% 12M change
Total Value Held $1.06 Million

William Jacob Savage Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 10 2024
BUY
Exercise of conversion of derivative security
$57,955 $2.65 p/Share
21,870 Added 33.5%
43,405 Common Stock
Jan 10 2024
BUY
Grant, award, or other acquisition
-
18,535 Added 46.26%
21,535 Common Stock
Aug 21 2023
BUY
Exercise of conversion of derivative security
$7,950 $2.65 p/Share
3,000 Added 50.0%
3,000 Common Stock
Aug 15 2023
SELL
Open market or private sale
$407,843 $53.16 p/Share
7,672 Reduced 100.0%
0 Common Stock
Aug 09 2023
SELL
Open market or private sale
$413,532 $50.01 p/Share
8,269 Reduced 51.87%
7,672 Common Stock
Jun 28 2023
SELL
Open market or private sale
$219,068 $49.97 p/Share
4,384 Reduced 21.57%
15,941 Common Stock
WJS

William Jacob Savage

Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX